John Olszewski

Array ( [id] => 11025407 [patent_doc_number] => 20160222362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'Target-Specific Double-Mutant Fusion Protein and Preparation Process Therefor' [patent_app_type] => utility [patent_app_number] => 14/889396 [patent_app_country] => US [patent_app_date] => 2014-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4851 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14889396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902266 [patent_doc_number] => 20150057465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'CONTROL OF GROWTH-INDUCTION-PRODUCTION PHASES' [patent_app_type] => utility [patent_app_number] => 14/215508 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27568 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14215508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12490803 [patent_doc_number] => 09994881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-12 [patent_title] => Functionalized carboxylic acids and alcohols by reverse fatty acid oxidation in engineered microbes [patent_app_type] => utility [patent_app_number] => 14/199528 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 28 [patent_no_of_words] => 21943 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11250579 [patent_doc_number] => 09476071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Process for the enzymatic synthesis of (7S)-3,4-dimethoxybicyclo[4.2.0]OCTA-1,3,5-triene-7-carboxylic acid and application in the synthesis of ivabradine and salts thereof' [patent_app_type] => utility [patent_app_number] => 14/190702 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4262 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11415406 [patent_doc_number] => 09562223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-07 [patent_title] => 'Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)' [patent_app_type] => utility [patent_app_number] => 13/999454 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 55722 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13999454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670628 [patent_doc_number] => 20140234490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'BUTTIAUXELLA SP. PHYTASE VARIANTS' [patent_app_type] => utility [patent_app_number] => 14/161548 [patent_app_country] => US [patent_app_date] => 2014-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24837 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14161548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9449423 [patent_doc_number] => 20140120593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'METHOD FOR PRODUCING USEFUL CHEMICAL SUBSTANCE FROM TEREPHTHALIC ACID POTASSIUM SALT' [patent_app_type] => utility [patent_app_number] => 14/143912 [patent_app_country] => US [patent_app_date] => 2013-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26793 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14143912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9616215 [patent_doc_number] => 20140206071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'METABOLICALLY ENGINEERED YEASTS FOR THE PRODUCTION OF ETHANOL AND OTHER PRODUCTS FROM XYLOSE AND CELLOBIOSE' [patent_app_type] => utility [patent_app_number] => 14/139559 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 30203 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14139559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561246 [patent_doc_number] => 20140178958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'Cyanobacterium sp. for Production of Compounds' [patent_app_type] => utility [patent_app_number] => 14/138123 [patent_app_country] => US [patent_app_date] => 2013-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 221 [patent_figures_cnt] => 221 [patent_no_of_words] => 61217 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656529 [patent_doc_number] => 20160002672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'PRODUCTION OF ISOPRENE, ISOPRENOID, AND ISOPRENOID PRECURSORS USING AN ALTERNATIVE LOWER MEVALONATE PATHWAY' [patent_app_type] => utility [patent_app_number] => 14/654424 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 65556 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 85 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561239 [patent_doc_number] => 20140178950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'GENETICALLY ENGINEERED MICROBIAL STRAINS INCLUDING CHLORELLA PROTOTHECOIDES LIPID PATHWAY GENES' [patent_app_type] => utility [patent_app_number] => 14/099704 [patent_app_country] => US [patent_app_date] => 2013-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40132 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14099704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11768112 [patent_doc_number] => 09376691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Fusion proteins useful for producing pinene' [patent_app_type] => utility [patent_app_number] => 14/091818 [patent_app_country] => US [patent_app_date] => 2013-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 14092 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9537140 [patent_doc_number] => 20140161788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/092336 [patent_app_country] => US [patent_app_date] => 2013-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24719 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14092336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039439 [patent_doc_number] => 09080137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Alpha-amylase variant with altered properties' [patent_app_type] => utility [patent_app_number] => 14/086558 [patent_app_country] => US [patent_app_date] => 2013-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 1 [patent_no_of_words] => 38809 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14086558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421772 [patent_doc_number] => 20140106423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'Method of Preparing Piceatannol Using Bacterial Cytochrome P450 and Composition Therefor' [patent_app_type] => utility [patent_app_number] => 14/041403 [patent_app_country] => US [patent_app_date] => 2013-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7114 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14041403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648403 [patent_doc_number] => 08802413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Cytotoxic ribonuclease variants' [patent_app_type] => utility [patent_app_number] => 14/014952 [patent_app_country] => US [patent_app_date] => 2013-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 7821 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14014952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560901 [patent_doc_number] => 09284564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Recombinant microorganisms comprising stereospecific diol dehydratase enzyme and methods related thereto' [patent_app_type] => utility [patent_app_number] => 14/011872 [patent_app_country] => US [patent_app_date] => 2013-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 16632 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9262623 [patent_doc_number] => 20130344552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'KETOREDUCTASE POLYPEPTIDES FOR THE REDUCTION OF ACETOPHENONES' [patent_app_type] => utility [patent_app_number] => 13/970284 [patent_app_country] => US [patent_app_date] => 2013-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 48791 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11929982 [patent_doc_number] => 09796967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-24 [patent_title] => 'Compositions related to controllable intervening protein sequences (CIPS) comprising reversible zinc-binding motifs and inteins' [patent_app_type] => utility [patent_app_number] => 14/418858 [patent_app_country] => US [patent_app_date] => 2013-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 34 [patent_no_of_words] => 27918 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9268711 [patent_doc_number] => 20140023628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'SITE-DIRECTED PEGYLATION OF ARGINASES AND THE USE THEREOF AS ANTI-CANCER AND ANTI-VIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/945938 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 15351 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945938 [rel_patent_id] =>[rel_patent_doc_number] =>)